-
公开(公告)号:US11059911B2
公开(公告)日:2021-07-13
申请号:US16242378
申请日:2019-01-08
申请人: UCB Biopharma SPRL
摘要: The present disclosure relates to a symmetric bispecific antibody of the class IgG4 comprising two heavy chains which each comprise a variable domain, CH1 domain and a hinge region, wherein in each heavy chain:
the cysteine in the CH1 domain which forms an inter-chain disulphide bond with a cysteine in a light chain is substituted with another amino acid; and
optionally one or more of the amino acids positioned in the upper hinge region is substituted with cysteine, wherein the constant region sequence of each heavy chain is similar or identical and the variable region in each heavy chain is different, formulations comprising the same, the use of each of the above in treatment and processes for preparing said antibodies and formulations.-
公开(公告)号:US10221251B2
公开(公告)日:2019-03-05
申请号:US14380309
申请日:2013-02-22
申请人: UCB Biopharma SPRL
摘要: The present disclosure relates to a symmetric bispecific antibody of the class IgG4 comprising two heavy chains which each comprise a variable domain, CH1 domain and a hinge region, wherein in each heavy chain: the cysteine in the CH1 domain which forms an inter-chain disulphide bond with a cysteine in a light chain is substituted with another amino acid; and optionally one or more of the amino acids positioned in the upper hinge region is substituted with cysteine, wherein the constant region sequence of each heavy chain is similar or identical and the variable region in each heavy chain is different, formulations comprising the same, the use of each of the above in treatment and processes for preparing said antibodies and formulations.
-
公开(公告)号:US20190202937A1
公开(公告)日:2019-07-04
申请号:US16242378
申请日:2019-01-08
申请人: UCB Biopharma SPRL
CPC分类号: C07K16/468 , C07K16/00 , C07K2317/31 , C07K2317/51 , C07K2317/522 , C07K2317/53
摘要: The present disclosure relates to a symmetric bispecific antibody of the class IgG4 comprising two heavy chains which each comprise a variable domain, CH1 domain and a hinge region, wherein in each heavy chain:the cysteine in the CH1 domain which forms an inter-chain disulphide bond with a cysteine in a light chain is substituted with another amino acid; and optionally one or more of the amino acids positioned in the upper hinge region is substituted with cysteine, wherein the constant region sequence of each heavy chain is similar or identical and the variable region in each heavy chain is different, formulations comprising the same, the use of each of the above in treatment and processes for preparing said antibodies and formulations.
-
公开(公告)号:US11352414B2
公开(公告)日:2022-06-07
申请号:US15123038
申请日:2015-03-05
申请人: UCB BIOPHARMA SPRL
发明人: Farnaz Fallah-Arani , Robert Anthony Griffin , David Paul Humphreys , Shirley Jane Peters , Bryan John Smith , Paul Edward Stephens
摘要: The invention relates to multimeric fusion proteins which bind to human Fc receptors. The invention also relates to therapeutic compositions comprising the proteins, and their use in the treatment of immune disorders.
-
5.
公开(公告)号:US20180044416A1
公开(公告)日:2018-02-15
申请号:US15554478
申请日:2016-03-04
申请人: UCB Biopharma SPRL
CPC分类号: C07K16/283 , A61K2039/505 , A61K2039/507 , C07K16/00 , C07K16/2848 , C07K2317/35 , C07K2317/41 , C07K2317/52 , C07K2317/524 , C07K2317/526 , C07K2317/53 , C07K2317/60 , C07K2317/70 , C07K2317/71 , C07K2317/92 , C07K2319/00 , C07K2319/02 , C07K2319/30 , C07K2319/74 , G01N33/53 , G01N33/6866 , G01N2333/57 , G01N2333/70535
摘要: The invention relates to polymeric Fc proteins which bind to human Fc-receptors and methods of screening said polymeric Fc proteins to alter their functional characteristics. The invention also relates to therapeutic compositions comprising the polymeric Fc proteins, and their use in the treatment of immune disorders.
-
-
-
-